Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include common findings: Seizure, Lactic acidosis, Status epilepticus, and Increased CSF lactate and others; and sometimes findings: Generalized hypotonia, Aspiration pneumonia, Sparse hair, and Craniofacial dystonia and others. 39 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 13 | Encephalopathy, Mutism, Poor speech |
NDUFA6 encodes NADH:ubiquinone oxidoreductase subunit A6 (128 aa). Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed to be not involved in catalysis. Required for proper complex I assembly.
Mitochondrial complex I deficiency, nuclear type 33 is associated with mutations in the NDUFA6 gene on chromosome 22.
NDUFA6 is classified as a druggable target (Enzyme category) with score 0.3.
Genetic testing for NDUFA6 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 7 common features.
No clinical trials have been registered for mitochondrial complex I deficiency, nuclear type 33.
4 publications have been identified in PubMed for mitochondrial complex I deficiency, nuclear type 33. Kisho has analyzed 3 by research type. Research spans Review / Meta-Analysis (33%), Basic Science / Preclinical (33%), and Gene Therapy / Novel Therapeutics (33%).
Kumari D (2026). [PMID: 41554758](https://pubmed.ncbi.nlm.nih.gov/41554758/). *Sci Rep*. [Basic Science / Preclinical]
Ősz F (2025). [PMID: 39857410](https://pubmed.ncbi.nlm.nih.gov/39857410/). *Antioxidants (Basel)*. [Review / Meta-Analysis]
Angelin A (2025). [PMID: 41398158](https://pubmed.ncbi.nlm.nih.gov/41398158/). *Nat Commun*. [Gene Therapy / Novel Therapeutics]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:01 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Muscles |
4 |
Generalized hypotonia, Axial hypotonia, Damage to the optic nerve (optic atrophy) |
Lungs and breathing | 4 | Aspiration pneumonia, Bronchiectasis, Difficulty breathing (respiratory insufficiency) |
Digestive system | 2 | Difficulty swallowing (dysphagia), Feeding difficulties |
Lab test results | 2 | Increased circulating lactate concentration, Decreased activity of mitochondrial complex I |
Head and neck | 1 | Craniofacial dystonia |
Metabolism | 1 | Metabolic acidosis |
Eyes | 1 | Damage to the optic nerve (optic atrophy) |
Growth and development | 1 | Intrauterine growth retardation |
Blood and immune system | 1 | Decreased total neutrophil count |